Skip to main content
. 2021 Oct 28;9(11):1556. doi: 10.3390/biomedicines9111556

Figure 3.

Figure 3

Two deep marine derived drugs are currently on the market: (a) Prialt® and (b) Yondelis®. The figure shows species and sampling depth from which the compounds have been isolated, their molecular targets and disease areas. (a) Ziconotide (Prialt®) was derived from the venom of a marine snail (Conus sp.) and is used for the treatment of severe pain. (b) Trabectedin, ET-743 (Yondelis®), was derived from a marine tunicate Ecteinascidia turbinate and is used for the treatment of soft tissue sarcoma and ovarian cancer.